Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Sep 10, 2015
Continuous Precipitation of Nano-Crystals, Cocrystals and Amorphous Solid Dispersions
Read more
Scientific Article
/ Sep 10, 2015
Screening Methodologies to Expedite the Formulation Development of Amorphous Solid Dispersions
Read more
Scientific Article
/ Jul 27, 2015
Hovione and Invion sign development agreement for first inhaled non-steroidal anti-inflammatory for asthma
Read more
Scientific Article